Berry Genomics partners with Tencent Cloud to embark on a new journey of AI-driven life and health

Sep 03, 2025 16:11 CST Updated Sep 04, 09:00

On September 2, Berry Genomics Co., Ltd.'s wholly-owned subsidiaryBeijing Berry Genomics Co., Ltd.`, a giant in the cloud computing field`Tencent Cloud Computing (Beijing) Co., Ltd.Officially signed the "Strategic Cooperation Agreement." Adhering to the principles of "leveraging strengths, mutual promotion, long-term cooperation, and win-win benefits," both parties have decided to deepen their collaboration.Exploring the Infinite Possibilities of Artificial Intelligence (AI) in the Field of Life and Health`, aiming at`Expand the depth and breadth of cooperation, and elevate both parties' objectives.Benefits, ushering in aIntegration of Life Health and Frontier TechnologyThe Journey of Transformation.

Tencent CloudIt is a cloud computing brand that Shenzhen Tencent Computer System Co., Ltd. has put great effort into building, providing government agencies, enterprise organizations, and individual developers from all countries and regions around the world with technology products and services in cloud computing, big data, artificial intelligence, etc. With outstanding technological capabilities, it creates rich industry solutions, builds an open and win-win cloud ecosystem, promotes the construction of the industrial internet, and helps various industries achieve digital upgrades.

Multi-dimensional Cooperation, Building AI Life Health Blueprint

Global Priority Cooperation with Tencent Medical Health Division on Tencent Cloud Services:Berry Genomics and Tencent Cloud Reach Agreement: Berry Genomics to Prioritize Tencent Cloud Services Globally

Collaboration on AI Applications in the Field of Reproductive Health with Tencent Medical Health Division:Reproductive health has always been a core business sector for Berry Genomics. Through this collaboration, both parties will focus on the application of artificial intelligence in the field of reproductive health. By utilizing AI technology to deeply analyze genetic data, more precise pre-pregnancy risk assessments and prenatal genetic disease screenings may be achieved.

Collaboration on the Application of Artificial Intelligence in the Field of Genetic Disease Testing with Tencent's Healthcare Division:Genetic Disease Testing is an Important Application Scenario of Genetic Testing. Berry Genomics Co., Ltd. and Shenzhen Tencent Computer System Co., Ltd. will jointly develop the application of AI technology in genetic disease testing. By learning and analyzing massive genetic disease gene data, the AI system can quickly and accurately identify genetic mutation sites related to genetic diseases, improving the sensitivity and specificity of testing. This will not only help doctors make diagnoses more quickly but also provide patients with more timely and effective treatment options.

Collaboration on AI applications with Tencent's Healthcare Division in the technology services sector:In the field of technology services, the two parties will jointly explore how to use AI technology to improve the quality and efficiency of genetic testing services.

Collaboration on AI Applications in Third-Generation Sequencing with Tencent's Healthcare Division:Third-generation sequencing technology plays an important role in genetic testing. Berry Genomics and Tencent Cloud will collaborate to advance the application of AI in the field of third-generation sequencing. By using AI algorithms to process and analyze third-generation sequencing data, it is possible to more accurately identify structural variations in genes, providing stronger support for the research and diagnosis of complex diseases.

Vision for Cooperation: Promoting the Comprehensive Upgrade of the Life and Health Industry

Berry Genomics and Tencent Cloud will carry out technology research and development and project promotion for artificial intelligence applications in specialized fields such as reproductive health, genetic disease testing, and scientific services. They aim to drive the implementation of artificial intelligence in life health scenarios and upgrade the healthcare industry by creating exemplary hospital system models through complementary strengths. These efforts involve improving the analytical accuracy and processing speed of genetic data, establishing a gene-based medical service system for individual users (C-end), and integrating genetic testing services with health management. The goal is to become a new traffic entry point for personal health management, while solidifying and expanding the company’s leading position in the genetic testing industry.